TNGX Stock Analysis: Buy, Sell, or Hold?
TNGX - Tango Therapeutics, Inc.
$29.20
0.84 (2.96%)
▲
5d:
-3.05%
30d:
-2.08%
90d:
+35.44%
BUY
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 04, 2026
20d
Get Alerted When TNGX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: TNGX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: TNGX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: TNGX is currently trading at $29.20, which is considered fair relative to its 30-day fair value range of $27.49 to $32.25.
Technical Outlook: Technically, TNGX is in a strong uptrend. The price is currently testing key support at $28.60. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $43.82 (+54.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TNGX is in a strong uptrend. The price is currently testing key support at $28.60. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $43.82 (+54.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$27.49 -
$32.25
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 54.5% below Wall St target ($43.82)
Trading Range Analysis
30-Day Trading Range
$27.49 -
$32.25
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$28.60
Resistance Level
$33.53
Current Trend
Strong Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-17.95
Wall Street Target
$43.82
(+54.5%)
Revenue Growth (YoY)
-100.0%
Profit Margin
-188.2%
Share & Embed Analysis
Last updated: July 14, 2026 1:00 PM ET
Data refreshes hourly during market hours. Next update: 2:00 PM
Data refreshes hourly during market hours. Next update: 2:00 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TNGX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Adam Crystal
SELL
38460 shares
2026-04-15
Adam Crystal
SELL
27000 shares
2026-04-01
Adam Crystal
SELL
12000 shares
2026-03-25
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 57 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$111 | 57 HOLD |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 62 BUY |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
12 analysts |
$20 | 63 BUY |
|
VERA
Vera Therapeutics Inc |
STRONG BUY
14 analysts |
$82 | 58 HOLD |
Advanced TNGX Option Strategies
Professional options setups generated by AI based on today's TNGX price and gamma walls.
